Position
Fidelity in Bicara Therapeutics Inc.
Back to the book · All holders of BCAX
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark $18.6M$19.89 → $29.69
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 3.35M | $56.3M | — | — | — | 0.0% |
| Q1 2026 | 2.1M | $41.8M | $19.89 | $6.43M | −$21M | 0.0% |
| Q2 2026 | 1.89M | $56.2M | $29.69 | $18.6M | −$4.13M | 0.0% |